Positive lateral lymph node turned negative after neoadjuvant therapy-surgery or observation?

Area of Science:

• Oncology
• Radiology
• Surgical Oncology

Background:

• Neoadjuvant chemoradiation and total mesorectal excision have improved rectal cancer local recurrence rates.
• Restaging magnetic resonance imaging (MRI) aids in assessing tumor response and organ-sparing strategies.
• The utility of restaging MRI for evaluating lateral lymph nodes in rectal cancer is not well-established.

Purpose of the Study:

• To evaluate the role of restaging MRI in assessing lateral lymph nodes after neoadjuvant therapy for rectal cancer.
• To determine the risk of lateral local recurrence based on restaging MRI findings of lateral lymph nodes.
• To inform clinical decision-making regarding surveillance and treatment of lateral lymph nodes.

Main Methods:

• Review of studies assessing restaging MRI for lateral lymph node evaluation in rectal cancer.
• Analysis of lateral local recurrence rates in relation to changes in lymph node size on restaging MRI.
• Examination of the predictive value of restaging MRI for lateral recurrence, particularly for smaller lymph nodes.

Main Results:

• Restaging MRI has a limited role in assessing lateral lymph node status, with a high risk of lateral local recurrence often persisting despite size reduction.
• Clinical decisions should primarily rely on the initial MRI scan.
• Watchful waiting may be considered for clinical complete responses with significant lateral lymph node downsizing (≤ 4.0 mm), but requires continuous surveillance.
• Enlargement of lateral lymph nodes during follow-up may warrant lateral lymph node dissection.
• Persistent malignant features in smaller lymph nodes (5.0-6.9 mm) on restaging MRI indicate a significant risk (13% at 4 years) of lateral recurrence.

Conclusions:

• Restaging MRI's utility in evaluating lateral lymph nodes for rectal cancer is limited.
• Clinical decisions for lateral lymph node management should integrate primary MRI findings and ongoing surveillance.
• Understanding the specific risks associated with lateral lymph node characteristics on restaging MRI is crucial for shared decision-making in rectal cancer care.